Narnolia

Narnolia

Toll Free No: 1800-103-7212

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE370.30-3.25 (-0.87 %)
PREV CLOSE ( ) 373.55
OPEN PRICE ( ) 372.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 32999
TODAY'S LOW / HIGH ( )367.00 378.50
52 WK LOW / HIGH ( )353.35 706.9
NSE370.60-3.45 (-0.92 %)
PREV CLOSE( ) 374.05
OPEN PRICE ( ) 371.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 370.60 (1110)
VOLUME 908245
TODAY'S LOW / HIGH( ) 367.10 378.60
52 WK LOW / HIGH ( )353.5 705.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
17Sep Glenmark receives Orphan Drug Designat
Glenmark Pharmaceuticals has been granted Orphan Drug Designation by US..
17Sep Glenmark gains on receiving Orphan Dru
Glenmark Pharmaceuticals is currently trading at Rs. 376.45, up by 2.90..
17Sep Glenmark Pharmaceuticals submits media
Glenmark Pharmaceuticals has informed about submission of media release..
10Sep Glenmark Pharma’s arm gets USFDA’s fin
Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., U..
10Sep Glenmark Pharmaceuticals submits media
With reference to ‘Glenmark Pharmaceuticals receives ANDA approval for C..
Financials
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit2278.4316221.12
Gross Profit 2769.44 18181.84
Operating Profit 3771.8518030.92
Net Sales 14987.9363048.67
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Hester Biosciences (BSE)
peergroup  1831.10 (2.96%)
M.Cap ( in Cr)1557.69
Dr. Reddys Lab (BSE)
peergroup  2737.50 (0.46%)
M.Cap ( in Cr)45482.40
TTK Healthcare (BSE)
peergroup  484.90 (2.08%)
M.Cap ( in Cr)685.18
Wintac (BSE)
peergroup  179.30 (4.18%)
M.Cap ( in Cr)179.73
Neuland Laboratories (BSE)
peergroup  502.90 (1.22%)
M.Cap ( in Cr)645.22
Shareholding Pattern
PROMOTERS 46.58%
MUTUAL FUNDS/UTI 4.88%
FI/BANKS/INSURANCE 2.62%
NON-INSTITUTION 14.71%
GOVERNMENT 0%
FII 0%
About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 18-11-1977. Its today's share price is 370.3. Its current market capitalisation stands at Rs 10448.69 Cr. In the latest quarter, company has reported Gross Sales of Rs. 70091.65 Cr and Total Income of Rs.74847.79 Cr. The company's management includes Saira Ramasastry, Harish Kuber, D R Mehta, Milind Sarwate, Julio F Ribeiro, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Directory

current IPO
  • --
upcoming IPO
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room